Nobuyo Maeda

976 citations
13 papers · 779 indexed · h-index 8
Topics
Heart Failure Treatment and Management (2 papers)Endoplasmic Reticulum Stress and Disease (2 papers)Neurogenesis and neuroplasticity mechanisms (2 papers)

In The Last Decade

Nobuyo Maeda

10 papers receiving 763 citations

Peers

Nobuyo Maeda
Comparison fields: 5 of 75
  • Molecular Biology 269
  • Surgery 196
  • Physiology 157
  • Rheumatology 143
  • Endocrinology, Diabetes and Metabolism 135
Replace Ranjana Poddar with:
Ranjana Poddar United States
Petter Vikman Sweden
Yutao Zhan China
Roberto Paternò Italy
Francesca Nardi Italy
Jeff C. Falcone United States
Beatriz Dorado Spain
Olga V. Savinova United States
M. Rimoldi Italy
Elena Beltramo Italy
Nobuyo Maeda relative to Ranjana Poddar United States Ranjana Poddar's profile →
Citations per field
00.5×2.7×
Ranjana Poddar · 1×
Citations per year

Countries citing papers authored by Nobuyo Maeda

Since Specialization
Citations

This map shows the geographic impact of Nobuyo Maeda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nobuyo Maeda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nobuyo Maeda more than expected).

Fields of papers citing papers by Nobuyo Maeda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nobuyo Maeda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nobuyo Maeda. The network helps show where Nobuyo Maeda may publish in the future.

Co-authorship network of co-authors of Nobuyo Maeda

This figure shows the co-authorship network connecting the top 25 collaborators of Nobuyo Maeda. A scholar is included among the top collaborators of Nobuyo Maeda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nobuyo Maeda. Nobuyo Maeda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
#WorkIndexed citations
1 0
2 0
3 2
4 0
5 2
6 35
7 26
8 254
9 8
10 70
11 198
12 175
13 9

About Nobuyo Maeda

Nobuyo Maeda is a scholar working on Developmental Neuroscience, Cell Biology and Immunology, having authored 13 papers that have together received 779 indexed citations. Recurring topics across this work include Heart Failure Treatment and Management (2 papers), Endoplasmic Reticulum Stress and Disease (2 papers) and Neurogenesis and neuroplasticity mechanisms (2 papers). The work is most often cited by research in Biochemistry (73 citations), Developmental Neuroscience (40 citations) and Rheumatology (143 citations). Nobuyo Maeda has collaborated with scholars based in United States, Japan and Switzerland. Frequent co-authors include Michael K. Altenburg, Myron E. Hinsdale, Christopher W. Knouff, Patrick M. Sullivan, Steven H. Quarfordt, Hafid Mezdour, Masahiko Watanabe, Jayme Borensztajn, Gregg E. Homanics and Jesús Osada. Their work appears in journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Journal of Neuroscience.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026